Twist Bioscience Corp

$113.11 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Twist Bioscience Corp

Twist Bioscience Corporation is a synthetic biology company. The Company is developing a disruptive deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company has a semiconductor-based synthetic DNA manufacturing process featuring 10,000-well silicon platform, which is capable of producing synthetic biology tools, such as genes, oligonucleotide pools and variant libraries. Its silicon-based DNA writing platform offers synthesis of genes on silicon. Its products include clonal perfect genes and non-clonal fragments. It offers protein scanning single variant libraries. Its design methodology, coupled with its silicon-based synthesis platform, enables synthesis of each library variant positioned exactly where user wants it to be. It offers unamplified oligo pools and cloning-ready oligo pools. Its platform offers synthesis of oligonucleotide pools for specific targeting.

Stock Analysis

last close $112.8
1-mo return -0.1%
3-mo return -0.1%
avg daily vol. 436.54T
52-week high 214.07
52-week low 74.25
market cap. $5.6B
forward pe -
annual div. -
roe -28.2%
ltg forecast -
dividend yield -
annual rev. $127M
inst own. -
baraka

Subscribe now for daily local and international financial news

Subscribe